Healthcare and pharma after the pandemic

What might be the enduring impact of the pandemic on healthcare delivery? Our panel discusses whether the digitisation of the space will accelerate further. We’ll also look at diagnostics, telemedicine and pharmaceuticals, including the issue of vaccines, and discuss the risks inherent in developing new products and technologies.